Hyperoxygenation attenuated a murine model of atopic dermatitis through raising skin level of ROS

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Kim, Hyung Ran ^a   Kim, Jung Hwan ^b,c   Choi, Eun Jeong ^a   Lee, Yeo Kyong ^d   Kie, Jeong Hae ^e   Jang, Myoung Ho ^b,c   Seoh, Ju Young ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Institute for Basic Science   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

^d Ewha Womans University   (South Korea)

^e National Health Insurance Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; GAMMA INTERFERON; HYDROETHIDINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN E; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 17; PERFLUORODECALIN; PREDNICARBATE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FOXP3; FLUOROCARBON; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; BAGG ALBINO MOUSE; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DISEASE MODEL; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERBARIC OXYGEN; HYPEROXIA; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE FUNCTION; MALE; MOUSE; MURINE MODEL; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DERMATITIS, ATOPIC; DRUG EFFECTS; METABOLISM; PATHOLOGY; PYROGLYPHIDAE; SKIN;

MURINAE;

ANIMALS; DERMATITIS, ATOPIC; DINITROCHLOROBENZENE; DISEASE MODELS, ANIMAL; FLUOROCARBONS; HYPERBARIC OXYGENATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; MICE; MICE, INBRED BALB C; OXYGEN; PYROGLYPHIDAE; REACTIVE OXYGEN SPECIES; SKIN;

EID: 84907546603     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109297     Document Type: Article

References (63)

1. Berke R, Singh A, Guralnick M (2012) Atopic dermatitis: An overview. Am Fam Physician 86: 35-42.
2. Del Rosso J, Friedlander SF (2005) Corticosteroids: options in the era of steroidsparing therapy. J Am Acad Dermatol 53: S50-58.
3. Lee K, Won HY, Bae MA, Hong JH, Hwang ES (2011) Spontaneous and agingdependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells. Proc Natl Acad Sci U S A 108: 9548-9553.
4. Won HY, Jang EJ, Min HJ, Hwang ES (2011) Enhancement of Allergeninduced Airway Inflammation by NOX2 Deficiency. Immune Netw 11: 169- 174.
5. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, et al. (2004) Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A 101: 12646-12651.
6. De Ravin SS, Naumann N, Cowen EW, Friend J, Hilligoss D, et al. (2008) Chronic granulomatous disease as a risk factor for autoimmune disease. J Allergy Clin Immunol 122: 1097-1103.
7. Won HY, Sohn JH, Min HJ, Lee K, Woo HA, et al. (2010) Glutathione peroxidase 1 deficiency attenuates allergen-induced airway inflammation by suppressing Th2 and Th17 cell development. Antioxid Redox Signal 13: 575- 587.
8. de Haan JB, Witting PK, Stefanovic N, Pete J, Daskalakis M, et al. (2006) Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet. J Lipid Res 47: 1157-1167.
9. Won HY, Jang EJ, Lee K, Oh S, Kim HK, et al. (2013) Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced Foxp3+ regulatory T cells. J Immunol 191: 4029-4037.
10. Kim HR, Lee A, Choi EJ, Hong MP, Kie JH, et al. (2014) Reactive Oxygen Species Prevent Imiquimod-Induced Psoriatic Dermatitis through Enhancing Regulatory T Cell Function. PLoS One 9: e91146.
11. Hultqvist M, Olsson LM, Gelderman KA, Holmdahl R (2009) The protective role of ROS in autoimmune disease. Trends Immunol 30: 201-208.
12. Efimova O, Szankasi P, Kelley TW (2011) Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells. PLoS One 6: e16013.
13. Jang MH, Jung YJ, Kim HR, Moon BI, Seoh JY (2011) Immune Homeostasis Maintained by Tregs. In: Hayashi RS, editor. Regulatory T cells. New York: Nova Science Publishers. 201-223.
14. Jung YJ, Seoh JY (2009) Feedback loop of immune regulation by CD4+CD25+ Treg. Immunobiology 214: 291-302.
15. Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, et al. (2010) Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A 107: 17686-17691.
16. George-Chandy A, Nordstrom I, Nygren E, Jonsson IM, Postigo J, et al. (2008) Th17 development and autoimmune arthritis in the absence of reactive oxygen species. Eur J Immunol 38: 1118-1126.
17. Munn DH, Mellor AL (2013) Indoleamine 2, 3 dioxygenase and metabolic control of immune responses. Trends Immunol 34: 137-143.
18. Ogasawara N, Oguro T, Sakabe T, Matsushima M, Takikawa O, et al. (2009) Hemoglobin induces the expression of indoleamine 2, 3-dioxygenase in dendritic cells through the activation of PI3 K, PKC, and NF-kappaB and the generation of reactive oxygen species. J Cell Biochem 108: 716-725.
19. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, et al. (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
20. Thomas SR, Stocker R (1999) Redox reactions related to indoleamine 2, 3- dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 4: 199-220.
21. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, et al. (2006) Tryptophan catabolism generates autoimmune-preventive regulatory T cells. Transpl Immunol 17: 58-60.
22. Favre D, Mold J, Hunt PW, Kanwar B, Loke P, et al. (2010) Tryptophan catabolism by indoleamine 2, 3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2: 32ra36.
23. Harden JL, Gu T, Kilinc MO, Rowswell-Turner RB, Virtuoso LP, et al. (2011) Dichotomous effects of IFN-gamma on dendritic cell function determine the extent of IL-12-driven antitumor T cell immunity. J Immunol 187: 126-132.
24. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, et al. (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146: 772-784.
25. Vann RD, Butler FK, Mitchell SJ, Moon RE (2011) Decompression illness. Lancet 377: 153-164.
26. Guzman JA (2012) Carbon monoxide poisoning. Crit Care Clin 28: 537-548.
27. Korhonen K (2000) Hyperbaric oxygen therapy in acute necrotizing infections. With a special reference to the effects on tissue gas tensions. Ann Chir Gynaecol 89 Suppl 214: 7-36.
28. Liu R, Li L, Yang M, Boden G, Yang G (2013) Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clin Proc 88: 166-175.
29. Olivieri AN, Mellos A, Duilio C, Di Meglio M, Mauro A, et al. (2010) Refractory vasculitic ulcer of the toe in an adolescent suffering from systemic lupus erythematosus treated successfully with hyperbaric oxygen therapy. Ital J Pediatr 36: 72.
30. Chen SY, Chen YC, Wang JK, Hsu HP, Ho PS, et al. (2003) Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB6NZW) F1 mice. Clin Immunol 108: 103-110.
31. Kudchodkar B, Jones H, Simecka J, Dory L (2008) Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice. Clin Immunol 128: 435-441.
32. Nagatomo F, Gu N, Fujino H, Okiura T, Morimatsu F, et al. (2010) Effects of exposure to hyperbaric oxygen on oxidative stress in rats with type II collageninduced arthritis. Clin Exp Med 10: 7-13.
33. Takeshima F, Makiyama K, Doi T (1999) Hyperbaric oxygen as adjunct therapy for Crohn's intractable enteric ulcer. Am J Gastroenterol 94: 3374-3375.
34. Buchman AL, Fife C, Torres C, Smith L, Aristizibal J (2001) Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol 33: 337-339.
35. Rachmilewitz D, Karmeli F, Okon E, Rubenstein I, Better OS (1998) Hyperbaric oxygen: A novel modality to ameliorate experimental colitis. Gut 43: 512-518.
36. Butler G, Michaels JC, Al-Waili N, Finkelstein M, Allen M, et al. (2009) Therapeutic effect of hyperbaric oxygen in psoriasis vulgaris: Two case reports and a review of the literature. J Med Case Rep 3: 7023.
37. Olszanski R, Pachut M, Sicko Z, Sztaba-Kania M, Wilkowska A (1992) Efficacy of hyperbaric oxygenation in atopic dermatitis. Bull Inst Marit Trop Med Gdynia 43: 79-82.
38. Faleo G, Fotino C, Bocca N, Molano RD, Zahr-Akrawi E, et al. (2012) Prevention of autoimmune diabetes and induction of beta-cell proliferation in NOD mice by hyperbaric oxygen therapy. Diabetes 61: 1769-1778.
39. Thom SR (2009) Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol (1985) 106: 988-995.
40. Thom SR (2011) Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg 127 Suppl 1: 131S-141S.
41. Lowe KC (2003) Engineering blood: synthetic substitutes from fluorinated compounds. Tissue Eng 9: 389-399.
42. Clark LC Jr, Gollan F (1966) Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152: 1755-1756.
43. Rizzo S, Belting C, Genovesi-Ebert F, Hagedorn N (2012) Colored perfluorocarbon liquids as novel intraoperative tools. Graefes Arch Clin Exp Ophthalmol 250: 653-659.
44. Gewiese BK, Noske W, Schilling AM, Stiller DA, Wolf KJ, et al. (1992) Human eye: visualization of perfluorodecalin with F-19 MR imaging. Radiology 185: 131-133.
45. Stanzl K, Zastrow L, Roding J, Artmann C (1996) The effectiveness of molecular oxygen in cosmetic formulations. Int J Cosmet Sci 18: 137-150.
46. Choi EJ, Lee S, Hwang JS, Im SH, Jun CD, et al. (2011) DA-9601 suppresses 2, 4-dinitrochlorobenzene and dust mite extract-induced atopic dermatitis-like skin lesions. Int Immunopharmacol 11: 1260-1264.
47. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, et al. (2001) Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 276: 17621-17624.
48. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL (1998) Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82: 1298-1305.
49. Kurien BT, Scofield RH (2008) Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 7: 567-573.
50. Selman C, Blount JD, Nussey DH, Speakman JR (2012) Oxidative damage, ageing, and life-history evolution: where now? Trends Ecol Evol 27: 570-577.
51. Ho YS, Magnenat JL, Bronson RT, Cao J, Gargano M, et al. (1997) Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem 272: 16644-16651.
52. Zhang Y, Ikeno Y, Qi W, Chaudhuri A, Li Y, et al. (2009) Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. J Gerontol A Biol Sci Med Sci 64: 1212-1220.
53. Esworthy RS, Aranda R, Martin MG, Doroshow JH, Binder SW, et al. (2001) Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 281: G848-855.
54. Taylor MW, Feng GS (1991) Relationship between interferon-gamma, indoleamine 2, 3-dioxygenase, and tryptophan catabolism. FASEB J 5: 2516- 2522.
55. Di Cesare A, Di Meglio P, Nestle FO (2008) A role for Th17 cells in the immunopathogenesis of atopic dermatitis? J Invest Dermatol 128: 2569-2571.
56. Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, et al. (2010) IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol 185: 5953-5961.
57. Kraaij MD, van der Kooij SW, Reinders ME, Koekkoek K, Rabelink TJ, et al. (2011) Dexamethasone increases ROS production and T cell suppressive capacity by anti-inflammatory macrophages. Mol Immunol 49: 549-557.
58. Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol 19: 223-229.
59. Gorlach A (2009) Regulation of HIF-1alpha at the transcriptional level. Curr Pharm Des 15: 3844-3852.
60. Rezvani HR, Ali N, Nissen LJ, Harfouche G, de Verneuil H, et al. (2011) HIF- 1alpha in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and noncancer disorders. J Invest Dermatol 131: 1793-1805.
61. Dennog C, Gedik C, Wood S, Speit G (1999) Analysis of oxidative DNA damage and HPRT mutations in humans after hyperbaric oxygen treatment. Mutat Res 431: 351-359.
62. Dennog C, Hartmann A, Frey G, Speit G (1996) Detection of DNA damage after hyperbaric oxygen (HBO) therapy. Mutagenesis 11: 605-609.
63. Narkowicz CK, Vial JH, McCartney PW (1993) Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun 19: 71-80.